We are live on ! Find out more
Ray Dalio

Ray Dalio Bridgewater Associates

AUM $22.4B
1-Year Est. Return 34.48%
 

Ray Dalio is the founder of Bridgewater Associates, one of the world’s largest hedge funds, known for its unique “principles-based” culture and systematic investment approach. Dalio’s investment philosophy emphasizes diversified portfolios, risk parity, and the importance of understanding economic cycles in shaping investment decisions. He has authored several books, including “Principles: Life & Work,” in which he details his management philosophies, personal experiences, and life lessons.

This Fund
S&P 500
This Quarter Est. Return
+5.83%
1 Year Est. Return
+34.48%
3 Year Est. Return
+84.29%
5 Year Est. Return
+89.92%
10 Year Est. Return
+230.06%
AUM
$14.9B
AUM Growth
+$3.99B
Cap. Flow
+$3.33B
Cap. Flow %
22.32%
Top 10 Hldgs %
82.14%
Holding
426
New
83
Increased
81
Reduced
92
Closed
140

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 1.98%
2 Healthcare 1.54%
3 Financials 1.2%
4 Technology 1.1%
5 Energy 1.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IDXX icon
276
Idexx Laboratories
IDXX
$46.2B
$271K ﹤0.01%
+1,743
New +$276K
JKHY icon
277
Jack Henry & Associates
JKHY
$11.1B
$238K ﹤0.01%
2,315
-2,195
-49% -$227K
TECH icon
278
Bio-Techne
TECH
$11.3B
$236K ﹤0.01%
7,820
-11,692
-60% -$347K
BXP icon
279
Boston Properties
BXP
$11.1B
$229K ﹤0.01%
1,860
-38,064
-95% -$4.61M
SJM icon
280
J.M. Smucker
SJM
$12.8B
$222K ﹤0.01%
+2,114
New +$241K
LNC icon
281
Lincoln National
LNC
$8.81B
$218K ﹤0.01%
2,963
-9,153
-76% -$646K
ATR icon
282
AptarGroup
ATR
$8.61B
$215K ﹤0.01%
2,490
-4,007
-62% -$341K
OI icon
283
O-I Glass
OI
$1.08B
$208K ﹤0.01%
8,266
-12,755
-61% -$309K
CCJ icon
284
Cameco
CCJ
$42.4B
$206K ﹤0.01%
21,432
-88,174
-80% -$875K
EQR icon
285
Equity Residential
EQR
$25.1B
$204K ﹤0.01%
+3,093
New +$207K
NUAN
286
DELISTED
Nuance Communications, Inc.
NUAN
$185K ﹤0.01%
13,608
-70,663
-84% -$1.01M
ACN icon
287
Accenture
ACN
$108B
-36,266
Closed -$4.49M
ADBE icon
288
Adobe
ADBE
$105B
-84,446
Closed -$11.9M
AFL icon
289
Aflac
AFL
$62.6B
-15,938
Closed -$619K
AGCO icon
290
AGCO
AGCO
$7.2B
-3,683
Closed -$248K
AJG icon
291
Arthur J. Gallagher & Co
AJG
$63.6B
-9,509
Closed -$544K
ALB icon
292
Albemarle
ALB
$15.5B
-14,937
Closed -$1.58M
ALV icon
293
Autoliv
ALV
$9B
-8,522
Closed -$674K
AMCX icon
294
AMC Global Media
AMCX
$489M
-12,339
Closed -$659K
AVY icon
295
Avery Dennison
AVY
$13.4B
-2,866
Closed -$253K
AYI icon
296
Acuity Brands
AYI
$10.8B
-1,202
Closed -$244K
BALL icon
297
Ball Corp
BALL
$16.8B
-11,315
Closed -$478K
BF.B icon
298
Brown-Forman Class B
BF.B
$13.1B
-8,258
Closed -$257K
BMY icon
299
Bristol-Myers Squibb
BMY
$132B
-131,064
Closed -$7.3M
CAKE icon
300
Cheesecake Factory
CAKE
$5.33B
-12,056
Closed -$606K

Similar funds

Ray Dalio's Q3 2017 Portfolio in Review

As of Q3 2017, Ray Dalio held 426 positions worth $14.9B, up 37% from $10.9B the previous quarter. Its ten largest holdings account for 82% of the portfolio.

Ray Dalio deployed $3.33B of net new capital in Q3 2017, opening 83 new positions and adding to 81 existing holdings. Its largest new stake was Quest Diagnostics: 208,121 shares worth $19.5M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 2% of assets, down from 2.4% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares MSCI South Korea ETF, an estimated $92.2M trimmed.

  • Ray Dalio's largest Q3 2017 buy was Quest Diagnostics: 208,121 shares worth $19.5M.
  • Ray Dalio added most to iShares Core MSCI Emerging Markets ETF in Q3 2017, an estimated $949M increase.
  • Ray Dalio's biggest Q3 2017 reduction was iShares MSCI South Korea ETF, cutting an estimated $92.2M.
  • Ray Dalio fully exited Chesapeake Energy Corporation in Q3 2017, selling an estimated $26.1M.
  • Ray Dalio's ten largest holdings make up 82% of its $14.9B portfolio in Q3 2017.
  • Ray Dalio opened 83 new positions and closed 140 in Q3 2017.
  • Ray Dalio's portfolio value rose 37% quarter-over-quarter to $14.9B.

Based on Bridgewater Associates's 13F filing for Q3 2017, filed 13 Nov 2017.